BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 38430086)

  • 1. Trajectories of Kidney Function in Heart Failure Over a 15-Year Follow-Up: Clinical Profiling and Mortality.
    Zamora E; Codina P; Aimo A; Lupón J; Domingo M; Troya M; Santiago-Vacas E; Cediel G; Borrellas A; Ruiz-Cueto M; Romero-González GA; Santesmases J; Nuñez J; Bover J; Ara J; Bayes-Genis A
    JACC Heart Fail; 2024 May; 12(5):849-859. PubMed ID: 38430086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Effect of Renal Function in Ambulatory Patients With Heart Failure and Reduced Ejection Fraction: The Kidney Is a Marker of Cardiac Function.
    Mascarenhas J; Laszczynska O; Severo M; Friões F; Alvelos M; Bettencourt P; Pimenta J; Azevedo A
    Can J Cardiol; 2018 Oct; 34(10):1325-1332. PubMed ID: 30201253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in Kidney Function Outcomes Following RAAS Inhibition in Patients With Heart Failure With Reduced Ejection Fraction.
    McCallum W; Tighiouart H; Ku E; Salem D; Sarnak MJ
    Am J Kidney Dis; 2020 Jan; 75(1):21-29. PubMed ID: 31303349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical characteristics and prognostic influence of renal dysfunction in heart failure patients with preserved ejection fraction.
    Casado J; Montero M; Formiga F; Carrera M; Urrutia A; Arévalo JC; Pérez-Calvo JI;
    Eur J Intern Med; 2013 Oct; 24(7):677-83. PubMed ID: 23830876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of glomerular filtration rate estimation equations in acute heart failure with preserved versus reduced ejection fraction.
    Casado Cerrada J; Carrasco Sánchez FJ; Pérez-Calvo JI; Manzano L; Formiga F; Aramburu Bodas O; Conde A; Quirós R; Pérez Bocanegra C; Montero-Pérez-Barquero M;
    Int J Clin Pract; 2015 Aug; 69(8):829-39. PubMed ID: 25651522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetes, gender and deterioration in estimated glomerular filtration rate in patients with chronic heart failure: Ten-year prospective cohort study.
    Kearney J; Drozd M; Walker AM; Slater TA; Straw S; Gierula J; Paton M; Lowry J; Cole C; Witte KK; Cubbon RM; Kearney MT
    Diab Vasc Dis Res; 2021; 18(1):1479164120984433. PubMed ID: 33588611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Implications of Estimating Glomerular Filtration Rate with Different Equations in Heart Failure Patients with Preserved Ejection Fraction.
    Zhang B; Liang H; Yu Z; Wei FF; Wu Y
    High Blood Press Cardiovasc Prev; 2024 Mar; 31(2):205-213. PubMed ID: 38584212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Machine Learning-Based Mortality Prediction in Chronic Kidney Disease among Heart Failure Patients: Insights and Outcomes from the Jordanian Heart Failure Registry.
    Izraiq M; Alawaisheh R; Ibdah R; Dabbas A; Ahmed YB; Mughrabi Sabbagh AL; Zuraik A; Ababneh M; Toubasi AA; Al-Bkoor B; Abu-Hantash H
    Medicina (Kaunas); 2024 May; 60(5):. PubMed ID: 38793014
    [No Abstract]   [Full Text] [Related]  

  • 9. Kidney Function and Outcomes in Patients Hospitalized With Heart Failure.
    Patel RB; Fonarow GC; Greene SJ; Zhang S; Alhanti B; DeVore AD; Butler J; Heidenreich PA; Huang JC; Kittleson MM; Joynt Maddox KE; McDermott JJ; Owens AT; Peterson PN; Solomon SD; Vardeny O; Yancy CW; Vaduganathan M
    J Am Coll Cardiol; 2021 Jul; 78(4):330-343. PubMed ID: 33989713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of serial decline of kidney function to predict mortality and cardiovascular events in patients undergoing coronary angiography.
    Rein P; Saely CH; Vonbank A; Boehnel C; Drexel H
    Am J Cardiol; 2014 Jan; 113(2):215-21. PubMed ID: 24169005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal dysfunction in patients with heart failure with preserved versus reduced ejection fraction: impact of the new Chronic Kidney Disease-Epidemiology Collaboration Group formula.
    McAlister FA; Ezekowitz J; Tarantini L; Squire I; Komajda M; Bayes-Genis A; Gotsman I; Whalley G; Earle N; Poppe KK; Doughty RN;
    Circ Heart Fail; 2012 May; 5(3):309-14. PubMed ID: 22441773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Routinely measured iohexol glomerular filtration rate versus creatinine-based estimated glomerular filtration rate as predictors of mortality in patients with advanced chronic kidney disease: a Swedish Chronic Kidney Disease Registry cohort study.
    Methven S; Gasparini A; Carrero JJ; Caskey FJ; Evans M
    Nephrol Dial Transplant; 2017 Apr; 32(suppl_2):ii170-ii179. PubMed ID: 28339801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal function in heart failure: a disparity between estimating function and predicting mortality risk.
    Plischke M; Neuhold S; Kohl M; Heinze G; Sunder-Plassmann G; Pacher R; Hülsmann M
    Eur J Heart Fail; 2013 Jul; 15(7):763-70. PubMed ID: 23429976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term prognostic value for patients with chronic heart failure of estimated glomerular filtration rate calculated with the new CKD-EPI equations containing cystatin C.
    Zamora E; Lupón J; de Antonio M; Vila J; Peñafiel J; Galán A; Urrutia A; Domingo M; Bayes-Genis A
    Clin Chem; 2014 Mar; 60(3):481-9. PubMed ID: 24255081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations with and prognostic impact of chronic kidney disease in heart failure with preserved, mid-range, and reduced ejection fraction.
    Löfman I; Szummer K; Dahlström U; Jernberg T; Lund LH
    Eur J Heart Fail; 2017 Dec; 19(12):1606-1614. PubMed ID: 28371075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic kidney disease and outcomes in heart failure with preserved versus reduced ejection fraction: the Cardiovascular Research Network PRESERVE Study.
    Smith DH; Thorp ML; Gurwitz JH; McManus DD; Goldberg RJ; Allen LA; Hsu G; Sung SH; Magid DJ; Go AS
    Circ Cardiovasc Qual Outcomes; 2013 May; 6(3):333-42. PubMed ID: 23685625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimated GFR Trajectories of People Entering CKD Stage 4 and Subsequent Kidney Disease Outcomes and Mortality.
    Xie Y; Bowe B; Xian H; Balasubramanian S; Al-Aly Z
    Am J Kidney Dis; 2016 Aug; 68(2):219-228. PubMed ID: 26948835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal Effects and Associated Outcomes During Angiotensin-Neprilysin Inhibition in Heart Failure.
    Damman K; Gori M; Claggett B; Jhund PS; Senni M; Lefkowitz MP; Prescott MF; Shi VC; Rouleau JL; Swedberg K; Zile MR; Packer M; Desai AS; Solomon SD; McMurray JJV
    JACC Heart Fail; 2018 Jun; 6(6):489-498. PubMed ID: 29655829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Renal Impairment on Beta-Blocker Efficacy in Patients With Heart Failure.
    Kotecha D; Gill SK; Flather MD; Holmes J; Packer M; Rosano G; Böhm M; McMurray JJV; Wikstrand J; Anker SD; van Veldhuisen DJ; Manzano L; von Lueder TG; Rigby AS; Andersson B; Kjekshus J; Wedel H; Ruschitzka F; Cleland JGF; Damman K; Redon J; Coats AJS;
    J Am Coll Cardiol; 2019 Dec; 74(23):2893-2904. PubMed ID: 31806133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-acteyl-ß-D-glucosaminidase and kidney injury molecule-1: New predictors for long-term progression of chronic kidney disease in patients with heart failure.
    Jungbauer CG; Uecer E; Stadler S; Birner C; Buchner S; Maier LS; Luchner A
    Nephrology (Carlton); 2016 Jun; 21(6):490-8. PubMed ID: 26422793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.